FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W16109203> ?p ?o ?g. }

• W16109203 abstract "Abstract Leukemic cell growth in the marrow microenvironment may be modulated by stromal cell products, including stimulatory growth factors and the inhibitory regulator prostaglandin E. The production of both of these stromal cell products induced by cytokine mediators appears to be closely linked. Cyclic AMP (cAMP) is an intracellular second messenger that inhibits myeloid cell proliferation and is produced in myeloid leukemia cells on stimulation of adenylate cyclase enzyme by prostaglandin E1 (PGE1). Cells expressing the product of an RAS oncogene have been observed to display diminished hormone-stimulated adenylate cyclase of membranes. If this observation were applicable to myeloid cells, a potentially important mode for leukemia cells expressing p21 RAS to escape inhibitory regulation within the hematopoietic microenvironment would be identified. We studied an interleukin-3 (IL-3)-dependent myeloid cell line, NFS/N1.H7, and a derivative line transfected with H-RAS codon 12 (T24) oncogene, H7 Neo Ras.F3, for inhibition of proliferation by PGE1, 1 microM, alone or in combination with pertussis toxin, which inactivates Gi, an inhibitory regulatory guanosine triphosphate (GTP)-binding protein of adenylate cyclase. NFS/N1.H7 cells were inhibited in interleukin-3-dependent proliferation (dose range, IL-3 10 to 100 U/mL) by PGE1 79 +/- 11%, by pertussis toxin 51 +/- 9%, and by the combination 92 +/- 2%, whereas H7 Neo RAS.F3 was inhibited 51 +/- 7%, 6 +/- 2%, or 58 +/- 9% by PGE1, pertussis toxin, and the combination, respectively. These differences in capacity for inhibition by adenylate cyclase agonists between RAS- transfectant cells (lower inhibition) versus parent cells (greater inhibition) were all highly significant (P less than .0005). Intracellular cAMP formed on PGE1 stimulation of pertussis-intoxicated cells was 150% lower in RAS-transfectant cells than in parent cells. The adenylate cyclase activity of membranes from pertussis-intoxicated RAS-transfected cells was 1.5 to two times lower than that of pertussis- intoxicated parent-cell membranes on Mg2+-dependent activation by hormone and/or guanine nucleotide. However, very similar adenylate cyclase activity was observed in oncogenic p21 RAS-containing membranes compared with parental membranes under conditions of direct activation by 4 mM Mn2+ and forskolin, where inhibitory or stimulatory G-protein influences are minimal. These studies showed diminished adenylate cyclase activity in mutant RAS-bearing myeloid-cell membranes compared with parent-cell membranes independent of the pertussis toxin-sensitive G protein, Gi.(ABSTRACT TRUNCATED AT 400 WORDS)." @default.
• W16109203 created "2016-06-24" @default.
• W16109203 creator A5015271236 @default.
• W16109203 creator A5023025642 @default.
• W16109203 creator A5052003347 @default.
• W16109203 creator A5075765460 @default.
• W16109203 date "1989-11-01" @default.
• W16109203 modified "2023-09-28" @default.
• W16109203 title "Effector function for RAS oncogene in interleukin-3-dependent myeloid cells involves diminished efficacy of prostaglandin E1-mediated inhibition of proliferation" @default.
• W16109203 cites W1038394818 @default.
• W16109203 cites W14556307 @default.
• W16109203 cites W1481677786 @default.
• W16109203 cites W1483985690 @default.
• W16109203 cites W1485278468 @default.
• W16109203 cites W1492360289 @default.
• W16109203 cites W1507560840 @default.
• W16109203 cites W1513011654 @default.
• W16109203 cites W151864754 @default.
• W16109203 cites W151869274 @default.
• W16109203 cites W1527111072 @default.
• W16109203 cites W1545004296 @default.
• W16109203 cites W1593219696 @default.
• W16109203 cites W1617966995 @default.
• W16109203 cites W1838818735 @default.
• W16109203 cites W1962723822 @default.
• W16109203 cites W196481606 @default.
• W16109203 cites W1967925725 @default.
• W16109203 cites W1971592219 @default.
• W16109203 cites W1978834984 @default.
• W16109203 cites W1990316739 @default.
• W16109203 cites W1993574643 @default.
• W16109203 cites W1994377324 @default.
• W16109203 cites W2003466423 @default.
• W16109203 cites W2005090417 @default.
• W16109203 cites W2008639995 @default.
• W16109203 cites W2012352438 @default.
• W16109203 cites W2035049668 @default.
• W16109203 cites W2035869432 @default.
• W16109203 cites W2049038993 @default.
• W16109203 cites W2062499314 @default.
• W16109203 cites W2064265012 @default.
• W16109203 cites W2082315237 @default.
• W16109203 cites W2091504157 @default.
• W16109203 cites W2091936831 @default.
• W16109203 cites W2102367506 @default.
• W16109203 cites W2103174300 @default.
• W16109203 cites W2119863891 @default.
• W16109203 cites W2127009121 @default.
• W16109203 cites W2156183673 @default.
• W16109203 cites W2164515753 @default.
• W16109203 cites W2169503005 @default.
• W16109203 cites W2202630179 @default.
• W16109203 cites W2246621605 @default.
• W16109203 cites W2405878472 @default.
• W16109203 cites W2406371987 @default.
• W16109203 cites W2409074158 @default.
• W16109203 cites W2410423662 @default.
• W16109203 cites W2410635907 @default.
• W16109203 cites W2433374115 @default.
• W16109203 cites W249476741 @default.
• W16109203 cites W4211131955 @default.
• W16109203 doi "https://doi.org/10.1182/blood.v74.6.1942.1942" @default.
• W16109203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2679912" @default.
• W16109203 hasPublicationYear "1989" @default.
• W16109203 type Work @default.
• W16109203 sameAs 16109203 @default.
• W16109203 citedByCount "7" @default.
• W16109203 crossrefType "journal-article" @default.
• W16109203 hasAuthorship W16109203A5015271236 @default.
• W16109203 hasAuthorship W16109203A5023025642 @default.
• W16109203 hasAuthorship W16109203A5052003347 @default.
• W16109203 hasAuthorship W16109203A5075765460 @default.
• W16109203 hasBestOaLocation W161092031 @default.
• W16109203 hasConcept C126322002 @default.
• W16109203 hasConcept C131665280 @default.
• W16109203 hasConcept C134018914 @default.
• W16109203 hasConcept C153911025 @default.
• W16109203 hasConcept C203014093 @default.
• W16109203 hasConcept C24998067 @default.
• W16109203 hasConcept C2776090121 @default.
• W16109203 hasConcept C2778690821 @default.
• W16109203 hasConcept C2779282312 @default.
• W16109203 hasConcept C2780069284 @default.
• W16109203 hasConcept C49773422 @default.
• W16109203 hasConcept C502942594 @default.
• W16109203 hasConcept C55493867 @default.
• W16109203 hasConcept C62112901 @default.
• W16109203 hasConcept C62478195 @default.
• W16109203 hasConcept C71924100 @default.
• W16109203 hasConcept C79484868 @default.
• W16109203 hasConcept C80631254 @default.
• W16109203 hasConcept C86803240 @default.
• W16109203 hasConcept C8891405 @default.
• W16109203 hasConcept C95444343 @default.
• W16109203 hasConceptScore W16109203C126322002 @default.
• W16109203 hasConceptScore W16109203C131665280 @default.
• W16109203 hasConceptScore W16109203C134018914 @default.
• W16109203 hasConceptScore W16109203C153911025 @default.
• W16109203 hasConceptScore W16109203C203014093 @default.
• W16109203 hasConceptScore W16109203C24998067 @default.

• next